Breaking Business News | Breaking business news AM | Breaking Business News PM | WATCH | Nestlé secures peanut allergy treatment

1 Sep 2020

Nestlé will pay $2 billion to buy the remaining stake in Aimmune Therapeutics, gaining full ownership of the first US-approved peanut allergy treatment.

Read the full article here.
This content was originally published by Fin24 News. Original publishers retain all rights. It appears here for a limited time before automated archiving. By Fin24 News

Covid-19 – Johns Hopkins University

Download brochure

Introduction brochure

What we do, case studies and profiles of some of our amazing team.